Michael Chang

Special Assistant to CEO @ APRINOIA Therapeutics

About

Business Development / Medical image (IRC) / CRO Industry / Radiopharmaceutical / In Vitro Diagnosis / Stem cell (regenerative medicine)

Country

City

Taiwan

Industry

Biotechnology

Skill

Fundrising, clinical trial operation, 策略規劃, Radiopharmaceuticals, Biotechnology, Molecular Biology, Cell Biology, Life Sciences, Cell Culture, Science, Pharmaceutical Industry, R&D, Technology Transfer, industrial analysis, Human Anatomy, Project Management, Good Clinical Practice (GCP)

Experience

Special Assistant to CEO

APRINOIA Therapeutics

2025-11 - Present · 11 mos

台北上海日本

Deeply involved in fundraising activities and IPO strategies.

Freelancer Medical Writing

Freelancer

2012 - Present · 14 yrs

SCI publication, Government grant project writing, and management. Up to date, our team provides the complete service and facilitates 20+ SCI publications and 5+ Government Grant Projects.

Vice President of Medical Affairs

PRIME life science

2024-9 - 2025-11 · 1 yr 3 mos

中國上海市

Director of Medical Sciences Affairs

思派健康科技

2021-5 - 2024-10 · 3 yrs 6 mos

上海市, 中國

Hands-on in clinical trial operation, including bidding, protocol writing, KOLs maintenance, and CDE on-site auditing.

Consultant of biotech industry solution

LinkDoc Technology

2021-5 - 2022-2 · 10 mos

徐匯區

Deeply involved in CAR-T related projects.

Director of Medical and Business department

Union image （Medical image CRO）

2018-7 - 2021-5 · 2 yrs 11 mos

張江高科

Hands on all the work in IRC medical image assessment. Act as science speaker to PI and related stakeholders also implement the business development strategy in the company

Manager of international business development

iStat Biomedical Co., Ltd

2016-5 - 2018-7 · 2 yrs 3 mos

New Taipei city

Planned and executed international trade shows (e.g., Medlab Dubai, Biomedica Summit in the Netherlands, AACC USA, Medica in Germany, ICOMS Philippines, Malaysia, and Vietnam) to successfully promote new products to over 10,000 potential customers. Customer and distributor development.

Laboratory Manager

TaiwanBio Therapeutic Co. Ltd.

2013-3 - 2016-5 · 3 yrs 3 mos

Taipei, Taiwan

Initiated and drafted the clinical trial protocol for OA (osteoarthritis) knee treated with human-derived mesenchymal stem cells. (NCT05027581) Initiated and drafted the clinical trial protocol for lower limb ischemia treated with human-derived mesenchymal stem cells. (NCT02336646)